Our investigation is the first to show that the likely pathogenic variants of the Cav1.3 encoding CACNA1D gene may play a role in ALS pathology and the associated dysregulation or loss of the pain sensation. The gene discussed is CACNA1D; the disease is amyotrophic lateral sclerosis.